A 2025 European clinical trial comparing a proprietary full-spectrum cannabis tincture (VER-01) with opioids for low-back pain found that over six months the cannabis tincture provided greater pain relief and improved sleep and was associated with a lower incidence of gastrointestinal adverse effects, including constipation.
October 20, 2025
high
temporal
Comparative effectiveness and safety outcomes reported from a 2025 European trial of a cannabis tincture versus opioid analgesics for low-back pain.
In 2025 the German company Vertanical developed a full-spectrum cannabis oil called VER-01 that was evaluated in European clinical trials for low-back pain.
October 20, 2025
high
temporal
Product and developer identification related to the 2025 clinical evaluations of a cannabis oil for low-back pain.